Puma Biotechnology Inc. (United States) is listed on the Nasdaq and has a market capitalization of $367.41 million, with shareholders equity totaling $146.61 million.
The company employs approximately 196 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Puma Biotechnology Inc. reported $231.83 million in revenue, generating net income of $23.83 million.
Key financial metrics include a P/E ratio of 15.42, a price-to-book (P/B) ratio of 2.51, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker PBYI.